The DOI matches its Crossref record; 8 of the 9 references it cites were found in a registry or an index.
The Phosphoinositide 3-Kinase Pathway
Abstract
Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components. The role of phosphoinositide 3-kinase (PI3K), which catalyzes the production of phosphatidylinositol-3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metabolism; and cytoskeletal rearrangements are highlighted. The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapuetic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of phosphoinositide-3-kinase (PI3K) by ligation of growth factors to their cellular receptors promotes recruitment of Akt to the plasma membrane and its subsequent activation 28.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [28]
Citations
Cites
Fruman, D. A., Meyers, R. E., & Cantley, L. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.481 · Cited by 1,382
Self-citationBrunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,208
Lawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,068
Regulation of C. elegans Life-Span by Insulinlike Signaling in the Nervous System
Wolkow, C. A., Kimura, K. D., Lee, M. S., & Ruvkun, G. (2000) · Science · doi:10.1126/science.290.5489.147 · Cited by 681
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 599
Clark, A. S., West, K. A., Streicher, S. A., & Dennis, P. A. (2002) · PubMed · Cited by 589
The lipid phosphatase SHIP2 controls insulin sensitivity
Clément, S., Krause, U., Desmedt, F., Tanti, J., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J. M., Doherty, M., Malaisse, W. J., et al. (2001) · Nature · doi:10.1038/35051094 · Cited by 377
Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival
Liu, D., Xiao-hong, Y., & Songyang, Z. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00733-8 · Cited by 135
Flagged first, then by citations
1 of the 9 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,027
Lu, Y., Yu, Q., Liu, J. H., Zhang, J., Wang, H., Koul, D., McMurray, J. S., Fang, X., Yung, W. K. A., Siminovitch, K. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303621200 · Cited by 264
Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer
Baselga, J. M. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s1-12 · Cited by 261
Genetic Markers in Triple-Negative Breast Cancer
Sporikova, Z., Koudeláková, V., Trojanec, R., & Hajdúch, M. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.07.023 · Cited by 270
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akinleye, A., Avvaru, P., Furqan, M., Song, Y., & Liu, D. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-88 · Cited by 260
Martin, M., Schifferle, R. E., Cuesta, N., Vogel, S. N., Katz, J., & Michalek, S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.717 · Cited by 265
Chiari, P. C., Bienengraeber, M. W., Pagel, P. S., Krolikowski, J. G., Kersten, J. R., & Warltier, D. C. (2004) · Anesthesiology · doi:10.1097/00000542-200501000-00018 · Cited by 258
Zhu, J., Huang, J., Tseng, P., Yang, Y.-T. C., Fowble, J. W., Shiau, C., Shaw, Y., Kulp, S. K., & Chen, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4063 · Cited by 258
Mechanism of sperm capacitation and the acrosome reaction: role of protein kinases
Ickowicz, D., Finkelstein, M., & Breitbart, H. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.81 · Cited by 256
mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo
Kwon, C.-H., Zhu, X., Zhang, J., & Baker, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2132711100 · Cited by 235
Tsimberidou, A. M. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2861-1 · Cited by 268
Zhao, H., Wang, J., Shao, W., Wu, C.-P., Chen, Z.-P., To, S.-S. T., & Li, W.-P. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0670-3 · Cited by 255
Firestone, G. L., Giampaolo, J. R., & O'Keeffe, B. A. (2003) · Cellular Physiology and Biochemistry · doi:10.1159/000070244 · Cited by 255
Optogenetic control of intracellular signaling pathways
Zhang, K., & Cui, B. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.11.007 · Cited by 254
Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapyPreprint
Logue, J. S., & Morrison, D. K. (2012) · Genes & Development · doi:10.1101/gad.186965.112 · Cited by 259
Mitochondrial H2O2 Regulates the Angiogenic Phenotype via PTEN Oxidation
Connor, K. M., Subbaram, S., Regan, K. J., Nelson, K. K., Mazurkiewicz, J. E., Bartholomew, P. J., Aplin, A. E., Tai, Y.-T., Aguirre-Ghiso, J., Flores, S. C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410690200 · Cited by 251
The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
Matsuoka, T., & Yashiro, M. (2014) · Cancers · doi:10.3390/cancers6031441 · Cited by 250
Signaling at the Slit Diaphragm
Benzing, T. R. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130167.30769.55 · Cited by 251
Targeting HER1/EGFR: A molecular approach to cancer therapy
Arteaga, C. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)70010-4 · Cited by 252
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies
Jiang, W. G., Martin, T. A., Parr, C., Davies, G., Matsumoto, K., & Nakamura, T. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.004 · Cited by 249
Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
Platt, F. M., Hurst, C. D., Taylor, C., Gregory, W. M., Harnden, P., & Knowles, M. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0898 · Cited by 253
Liu, L., Singareddy, R., Reddy, P., Du, C., Jagarlamudi, K., Shen, Y., Gunnarsson, D., Selstam, G., Boman, K., & Liu, K. (2006) · Development · doi:10.1242/dev.02667 · Cited by 248
Scaffolding function of PAK in the PDK1–Akt pathway
Higuchi, M., Onishi, K., Kikuchi, C., & Gotoh, Y. (2008) · Nature Cell Biology · doi:10.1038/ncb1795 · Cited by 247
Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
Johnson, S. M., Gulhati, P., Rampy, B. A., Han, Y., Rychahou, P. G., Doan, H. Q., Weiss, H. L., & Evers, B. M. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.12.008 · Cited by 251
Tong, M., Neusner, A. D., Longato, L., Lawton, M., Wands, J. R., & de la Monte, S. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1115 · Cited by 249
Akt as a mediator of cell death
Luo, H. R., Hattori, H., Hossain, M. A., Hester, L. D., Huang, Y., Lee‐Kwon, W., Donowitz, M., Nagata, E., & Snyder, S. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1634990100 · Cited by 245
Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production
Kimura, T., Suzuki, A., Fujita, Y., Yomogida, K., Lomelı́, H., Asada, N., Ikeuchi, M., Nagy, A., Mak, T. W., & Nakano, T. (2003) · Development · doi:10.1242/dev.00392 · Cited by 244
PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice
Schabbauer, G., Tencati, M., Pedersen, B., Pawliński, R., & Mackman, N. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143096.15099.ce · Cited by 247
Cardiac regulation by phosphoinositide 3-kinases and PTEN
Oudit, G. Y., & Penninger, J. M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp014 · Cited by 243
Autophagy, lipophagy and lysosomal lipid storage disorders
Ward, C., Martínez-López, N., Otten, E. G., Carroll, B., Maetzel, D., Singh, R., Sarkar, S., & Korolchuk, V. I. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.006 · Cited by 254
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
Fischer, R., Kontermann, R. E., & Pfizenmaier, K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00401 · Cited by 255
Reddy, P., Adhikari, D., Zheng, W., Liang, S., Hämäläinen, T. M., Töhönen, V., Ogawa, W., Noda, T., Volarević, S., Huhtaniemi, I. T., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp217 · Cited by 248
Cao, X., Kambe, F., Moeller, L. C., Refetoff, S., & Seo, H. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0093 · Cited by 241
Xu, C., Liu, B., Wu, J., Xu, Y., Duan, X.-H., Cao, Y., & Dong, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.012 · Cited by 244
The deficiency of Akt1 is sufficient to suppress tumor development in Pten +/− micePreprint
Chen, M.-L., Xu, P.-Z., Peng, X.-D., Chen, W. S., Guzman, G., Yang, X., Cristofano, A. D., Pandolfi, P. P., & Hay, N. (2006) · Genes & Development · doi:10.1101/gad.1395006 · Cited by 241
Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
Jiang, B., & Liu, L.-Z. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.03.001 · Cited by 249
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Hardie, W. D., Glasser, S. W., & Hagood, J. S. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081170 · Cited by 244
Ngkelo, A., Meja, K., Yeadon, M., Adcock, I., & Kirkham, P. A. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-1 · Cited by 238
SYMPOSIUM REVIEW: Phosphoinositides: lipid regulators of membrane proteins
Falkenburger, B. H., Jensen, J. B., Dickson, E. J., Suh, B., & Hille, B. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.192153 · Cited by 251
Roles of Gβγ in membrane recruitment and activation of p110γ/p101 phosphoinositide 3-kinase γ
Brock, C., Schaefer, M., Reusch, H. P., Czupalla, C., Michalke, M., Spicher, K., Schultz, G., & Nürnberg, B. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200210115 · Cited by 238
Zhao, W., Yu, S., Lu, Z., Ma, Y., Gu, Y., & Chen, J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq160 · Cited by 245
PTEN and PI3K/AKT in Non-Small-Cell Lung Cancer
Pérez-Ramírez, C., Cañadas‐Garre, M., Molina‐Vila, M. Á., Faus-Dáder, M. J., & Calleja‐Hernández, M. Á. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.122 · Cited by 246
Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a
Fine, B. M., Hodakoski, C., Koujak, S., Su, T., Saal, L. H., Maurer, M., Hopkins, B. D., Keniry, M. E., Sulis, M. L., Mense, S. M., et al. (2009) · Science · doi:10.1126/science.1173569 · Cited by 238
Maroulakou, I. G., Oemler, W., Naber, S. P., & Tsichlis, P. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3782 · Cited by 242
Knobbe-Thomsen, C. B., & Reifenberger, G. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00481.x · Cited by 236
Ehrhardt, C., Marjuki, H., Wolff, T., Nürnberg, B., Planz, O., Pleschka, S., & Ludwig, S. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00713.x · Cited by 238
Eyster, K. M. (2007) · AJP Advances in Physiology Education · doi:10.1152/advan.00088.2006 · Cited by 249
Park, S. E., Sapkota, K., Kim, S. H., Kim, H., & Kim, S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01389.x · Cited by 239
Lehmann, D. M., Seneviratne, A. M. P. B., & Smrcka, A. V. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041780 · Cited by 234
AKT and ERK dual inhibitors: The way forward?
Cao, Z., Liao, Q., Su, M., Huang, K., Jin, J., & Cao, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.025 · Cited by 244
PI3Kγ inhibition: towards an 'aspirin of the 21st century'?
Rückle, T., Schwarz, M. K., & Rommel, C. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2145 · Cited by 233
Shankar, S., & Srivastava, R. K. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.905 · Cited by 235
Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2
Woulfe, D. S., Jiang, H., Morgans, A. K., Monks, R., Birnbaum, M. J., & Brass, L. F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20267 · Cited by 232
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Guo, N., Wang, X., Xu, M., Bai, J., Yu, H., & Zhang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107300 · Cited by 237
Regulation of Src Family Kinases in Human Cancers
Sen, B., & Johnson, F. M. (2011) · Journal of Signal Transduction · doi:10.1155/2011/865819 · Cited by 235
Cardiac specific differentiation of mouse embryonic stem cells
Sachinidis, A. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00248-7 · Cited by 230
PI3K/Akt/mTOR inhibitors in breast cancer.
Lee, J. J. X., Loh, K. W.-J., & Yap, Y. S. (2015) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2015.0089 · Cited by 230
Nagoshi, T., Matsui, T., Aoyama, T., Leri, A., Anversa, P., Li, L., Ogawa, W., del Monte, F., Gwathmey, J. K., Grazette, L. P., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23073 · Cited by 229
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
Zhang, J., Dang, F., Ren, J., & Wei, W. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.09.004 · Cited by 233
Rao, G., Pedone, C. A., Valle, L. D., Reiss, K., Holland, E. C., & Fults, D. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207818 · Cited by 231
Hsieh, A. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh238 · Cited by 232
IQGAP1 and its binding proteins control diverse biological functions
White, C. D., Erdemir, H. H., & Sacks, D. B. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.005 · Cited by 233
Osteogenic Differentiation of Periosteal Cells During Fracture Healing
Wang, T., Zhang, X., & Bikle, D. D. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25641 · Cited by 227
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
Jiang, Y. Y., Jiang, Y.-Y., Xie, J., Mayakonda, A., Hazawa, M., Chen, L., Xiao, J.-F., Li, C., Huang, M., Ding, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06081-9 · Cited by 227
Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., & Kunos, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.699 · Cited by 227
FOXO Transcription Factors in Cell-Cycle Regulation and the Response to Oxidative Stress
Furukawa‐Hibi, Y., Kobayashi, Y., Chen, C., & Motoyama, N. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.752 · Cited by 228
The slit diaphragm: a signaling platform to regulate podocyte function
Huber, T. B., & Benzing, T. R. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000165885.85803.a8 · Cited by 225
Chang, J., Xie, M., Shah, V. R., Schneider, M. D., Entman, M. L., Wei, L., & Schwartz, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601911103 · Cited by 231
Sutherlin, D. P., Bao, L., Berry, M., Castanedo, G. M., Chuckowree, I., Dotson, J., Folks, A., Friedman, L. S., Goldsmith, R. A., Gunzner, J. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2009327 · Cited by 224
Pozo‐Guisado, E., Merino, J. M., Mulero‐Navarro, S., Lorenzo‐Benayas, M. J., Centeno, F., Alvarez, A. M., & Fernández‐Salguero, P. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.20856 · Cited by 223
Bolster, D. R., Jefferson, L. S., & Kimball, S. R. (2004) · Proceedings of The Nutrition Society · doi:10.1079/pns2004355 · Cited by 231
IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation
Xie, X., Zhang, D., Zhao, B., Lu, M.-K., You, M., Condorelli, G., Wang, C.-Y., & Guan, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016132108 · Cited by 226
Goodall, K. J., Poon, I. K. H., Phipps, S., & Hulett, M. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109596 · Cited by 223
Second MessengersPreprint
Newton, A. C., Bootman, M. D., & Scott, J. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005926 · Cited by 239
Hsp90 Recognizes a Common Surface on Client Kinases
Citri, A., Harari, D., Shohat-Ophir, G., Ramakrishnan, P., Gan, J., Lavi, S., Eisenstein, M., Kimchi, A., Wallach, D., Pietrokovski, S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512613200 · Cited by 222
Runyan, C. E., Schnaper, H. W., & Poncelet, A.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310412200 · Cited by 222
DeBerardinis, R. J., Lum, J. J., & Thompson, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608372200 · Cited by 221
Liu, K., Singareddy, R., Liu, L., Jagarlamudi, K., Boman, K., Selstam, G., & Reddy, P. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.07.038 · Cited by 227
Probing phosphoinositide functions in signaling and membrane trafficking
Downes, C. P., Gray, A., & Lucocq, J. M. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.008 · Cited by 226
PKB and the mitochondria: AKTing on apoptosis
Parcellier, A., Tintignac, L. A. J., Zhuravleva, E., & Hemmings, B. A. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.010 · Cited by 223
Siddiqui, N., & Sonenberg, N. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150126 · Cited by 225
Bridging the GAP between insulin signaling and GLUT4 translocation
Watson, R. T., & Pessin, J. E. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.02.007 · Cited by 222
PIK3CA and PTEN Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia
Hayes, M. P., Wang, H., Espinal-Witter, R., Douglas, W., Solomon, G. J., Baker, S. J., & Ellenson, L. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1375 · Cited by 218
Street, A., Macdonald, A., Crowder, K., & Harris, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312245200 · Cited by 225
Heparanase Induces Endothelial Cell Migration via Protein Kinase B/Akt Activation
Gingis‐Velitski, S., Zetser, A., Flugelman, M. Y., Vlodavsky, I., & Ilan, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400554200 · Cited by 218
Mammalian heparanase: what is the message?
Vreys, V., & David, G. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00039.x · Cited by 222
Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression
Rhee, K., Lee, J. E., & Eom, Y. W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226215 · Cited by 221
Phosphoinositide 3-Kinase Signaling to Akt Promotes Keratinocyte Differentiation Versus Death
Calautti, E., Li, J., Saoncella, S., Brissette, J. L., & Goetinck, P. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506119200 · Cited by 216
Prodrugs of biologically active phosphate esters
Schultz, C. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00552-7 · Cited by 216
VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy
Rahimi, N. (2006) · Frontiers in bioscience · doi:10.2741/1839 · Cited by 222
Glycogen synthase kinase 3: A point of convergence for the host inflammatory response
Wang, H., Brown, J. R., & Martin, M. (2010) · Cytokine · doi:10.1016/j.cyto.2010.10.009 · Cited by 222
Txnip balances metabolic and growth signaling via PTEN disulfide reduction
Hui, S. T. Y., Andres, A. M., Miller, A. K., Spann, N. J., Potter, D. W., Post, N. M., Chen, A. Z., Sachithanantham, S., Jung, D. Y., Kim, J. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800293105 · Cited by 214
Insulin action at a molecular level – 100 years of progress
White, M. F., & Kahn, C. R. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101304 · Cited by 221
PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches
Ligresti, G., Militello, L., Steelman, L. S., Cavallaro, A., Basile, F., Nicoletti, F., Stivala, F., McCubrey, J. A., & Libra, M. (2009) · Cell Cycle · doi:10.4161/cc.8.9.8255 · Cited by 214
Bock, H. H., Jossin, Y., Liu, P., Förster, E., May, P., Goffinet, A. M., & Herz, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306416200 · Cited by 213
Ilić, N., Utermark, T., Widlund, H. R., & Roberts, T. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108237108 · Cited by 217
Oxidative Stress and Neuronal Death/Survival Signaling in Cerebral Ischemia
Saito, A., Maier, C. M., Narasimhan, P., Nishi, T., Song, Y. S., Yu, F., Liu, J., Lee, Y., Nito, C., Kamada, H., et al. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:105 · Cited by 213
Liposarcoma: Molecular Genetics and Therapeutics
Conyers, R. K., Young, S., & Thomas, D. M. (2010) · Sarcoma · doi:10.1155/2011/483154 · Cited by 219
Sautin, Y. Y., Lu, M., Gaugler, A. C., Zhang, L., & Gluck, S. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.575-589.2005 · Cited by 221
Li, X., & Wang, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.44943 · Cited by 220
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Aoyagi, T., & Matsui, T. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796390976 · Cited by 218
Metadata
- Authors
- Cantley, L. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Cantley, Lewis C.
- ORCID
- Cantley, Lewis C.
- Venue
- Science
- Published
- 2002-05-31
- Volume
- 296
- Issue
- 5573
- Pages
- 1655-1657
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2070732456
- Cited by
- 5,621
- References
- 9
- Citations by year
- 2026: 87 · 2025: 137 · 2024: 134 · 2023: 182 · 2022: 200 · 2021: 203 · 2020: 216 · 2019: 215 · 2018: 232 · 2017: 276 · 2016: 243 · 2015: 297 · 2014: 292 · 2013: 306 · 2012: 325
- FWCI
- 76.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM041890)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- phosphatidylinositol 3-kinase, PI3K signaling, phosphatidylinositol 3,4,5-trisphosphate, cell survival signaling, gene expression regulation, cellular metabolism, cytoskeletal rearrangement, diabetes mellitus, cancer, therapeutic target
- MeSH terms
- Animals, Cell Membrane, Cell Physiological Phenomena, Diabetes Mellitus, Type 2, Humans, Models, Biological, Neoplasms, Phosphorylation, Protein Kinases, Proto-Oncogene Proteins, Signal Transduction, Protein Serine-Threonine Kinases, Phosphatidylinositol Phosphates, Phosphatidylinositol 4,5-Diphosphate, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review